Outset Medical Net Change in Short-term Investments 2019-2025 | OM
Outset Medical net change in short-term investments from 2019 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
| Outset Medical Annual Net Change in Short-term Investments (Millions of US $) |
|
|---|---|
| 2024 | $105 |
| 2023 | $86 |
| 2022 | $-58 |
| 2021 | $-139 |
| 2020 | $13 |
| 2019 | $78 |
| 2018 | $-67 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.359B | $0.114B |
| Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.108B | 58.66 |
| Hims & Hers Health (HIMS) | United States | $12.792B | 132.91 |
| Tempus AI (TEM) | United States | $12.331B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.644B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.793B | 59.27 |
| Privia Health (PRVA) | United States | $2.768B | 189.17 |
| Hinge Health (HNGE) | United States | $2.732B | 0.00 |
| Enovis (ENOV) | United States | $1.845B | 10.28 |
| Schrodinger (SDGR) | United States | $1.676B | 0.00 |
| Phreesia (PHR) | United States | $1.584B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.491B | 0.00 |
| Omnicell (OMCL) | United States | $1.403B | 24.74 |
| Azenta (AZTA) | United States | $1.392B | 64.70 |
| 10x Genomics (TXG) | United States | $1.303B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.639B | 0.00 |
| Claritev (CTEV) | United States | $0.620B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.603B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 150.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 792.33 |
| Health Catalyst (HCAT) | United States | $0.277B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.258B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.48 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |